Venous disorders include diseases in which blood encounters an obstacle to outflow, flows back in an abnormal direction because of valvular incompetence, or clots within the vessel. These processes may affect superficial and deep veins, produce local manifestations or have consequences for the pulmonary circulation and the right side of the heart. Venous thromboembolic disease brings deep vein thrombosis and pulmonary embolism together within a single biological framework: a thrombus formed in the venous system may remain at its site of origin, propagate or fragment, reaching the pulmonary arteries through the right heart chambers. The embolism is therefore venous in terms of the usual origin of the material, but the resulting obstruction occurs on the arterial side of the pulmonary circulation.
Chronic venous disease represents a different, although related, spectrum of disorders. Varicose veins, edema, skin changes and ulceration arise primarily from a persistent alteration in venous hemodynamics and do not presuppose a thrombotic episode. When damage follows deep vein thrombosis, however, the connection is direct: residual obstruction and valve destruction may keep venous pressure elevated during walking, giving rise to post-thrombotic syndrome. Distinguishing the initial process from its consequences prevents a varicose vein, a recent thrombus and the fibrotic sequela of an old thrombosis from being assigned the same clinical significance.
Epidemiological estimates of venous thromboembolism in the general population commonly range around 1–2 events per 1,000 people per year, with a marked increase at older ages and in the settings of hospitalization, surgery and malignancy. Chronic venous disease is much more common, but the percentages depend on the definition used: including telangiectasias and reticular veins produces much higher prevalence estimates than counting only venous insufficiency accompanied by edema, skin damage or ulceration. The healthcare impact also differs: thromboembolism can cause a life-threatening emergency, whereas chronic forms primarily result in disability, pain, recurrence of lesions and the need for prolonged care.
Venous return depends on the interaction between the pressure gradient, respiration, muscle contraction and valve integrity. In the lower extremities, the deep system carries most of the blood toward the heart; superficial veins drain the tissues above the fascia and communicate with deep veins through perforating veins. During calf contraction, compression of the deep veins propels blood proximally, while the valves limit downward backflow. During relaxation, the system fills again. Proper functioning of the muscle pump reduces distal venous pressure during walking; an ineffective pump, an obstacle to outflow or significant reflux prevents this reduction.
Venous physiology therefore cannot be compared to that of a simple passive tube. The high distensibility of veins, the dependent position of the limbs and their dependence on movement explain why immobility, obesity, limited ankle mobility and valvular abnormalities can profoundly alter drainage, although through different mechanisms.
Thrombosis develops when fibrin production and persistence overwhelm the systems that normally maintain blood fluidity. Virchow's triad comprises three interacting components: slowing of blood flow, alteration of the vessel wall or its endothelial lining, and hypercoagulability. Surgery, trauma, malignancy, pregnancy, estrogen treatments and immobilization are not necessarily required or sufficient causes in every individual; they are exposures that increase the likelihood of thrombosis, often acting simultaneously on several components of the triad. An intravascular catheter, by contrast, may cause direct local injury, associated with a reduction in the available lumen and disruption of flow.
Hereditary predisposition operates through coagulation abnormalities, such as factor V Leiden resistance to activated protein C, the prothrombin variant, or deficiencies of antithrombin, protein C and protein S. Antiphospholipid antibody syndrome is a distinct acquired condition in which autoantibodies and cellular activation promote venous and arterial events and obstetric complications.
In the veins of the lower extremities, valve pockets are particularly favorable sites for thrombus initiation. Stagnation limits blood renewal and may create a hypoxic microenvironment in which the endothelium loses some of its anticoagulant properties and expresses molecules that facilitate leukocyte recruitment. Tissue factor, originating from activated cells and extracellular vesicles, initiates thrombin generation; thrombin then converts fibrinogen into fibrin and amplifies coagulation. Platelets also participate in the process, although venous thrombi generally contain a substantial erythrocyte and fibrin component.
Inflammation is not merely a response to the presence of the clot. Monocytes, neutrophils and endothelial mediators can promote its initiation and growth; neutrophil extracellular traps provide, in experimental models and biological observations, a framework capable of interacting with cells and coagulation factors. However, the relevance of these pathways for new treatments must be distinguished from therapeutic indications already demonstrated in humans.
When a thrombotic fragment reaches the lungs, vascular obstruction and vasoconstriction increase the load against which the right ventricle must contract. The severity of acute pulmonary embolism depends on the interaction between obstruction, vascular response and cardiopulmonary reserve. A suddenly overloaded right ventricle dilates; increased wall tension raises oxygen consumption, while hypotension may reduce coronary perfusion. Septal displacement and reduced flow through the lungs decrease left ventricular filling and systemic cardiac output, potentially progressing to obstructive shock.
At the same time, ventilated but poorly perfused regions increase dead space; redistribution of blood flow, atelectasis and reduced oxygenation of venous blood contribute to hypoxemia. Pulmonary infarction does not necessarily accompany every embolism, partly because of the lung’s dual blood supply, but it may occur with peripheral occlusions and account for pleuritic pain and hemoptysis.
In chronic venous disease, the principal pathophysiological problem is ambulatory venous hypertension. Superficial, deep or perforator vein reflux allows blood to return toward distal segments; iliac obstruction or post-thrombotic sequelae instead impede outflow. Elevated pressure is transmitted to the microcirculation, increases filtration, promotes extravasation of erythrocytes and proteins, and recruits inflammatory cells. The lymphatic system initially compensates for some of the excess fluid load but may eventually become insufficient. Hemosiderin deposits, eczema, subcutaneous fibrosis and impaired tissue repair are possible stages of this process.
Forms of chronic venous insufficiency may therefore result from primary disease of the venous wall and valves or from secondary lesions. Venous dilation separates the valve leaflets, reflux increases the hemodynamic burden, and changes in the extracellular matrix promote further dilation: a cycle of progression develops, although this does not mean that every varicose vein will inevitably progress to an ulcer.
Certain anatomical configurations confer specific risks. May–Thurner syndrome refers to clinically significant iliac vein compression, which must be distinguished from incidental anatomical compressions that are common in asymptomatic people. In Paget–Schroetter syndrome, the interaction between the axillosubclavian vein, the thoracic outlet and arm activity may cause effort-related thrombosis. A venous aneurysm introduces a focal dilation in which blood flow and the distribution of mechanical stresses may be altered; certain deep locations, such as the popliteal vein, may constitute a source of emboli. These conditions illustrate how a thrombotic event does not always depend on a systemic coagulation abnormality and how treatment may sometimes also need to correct the underlying anatomical substrate.
History-taking begins with the time of symptom onset and their distribution. Unilateral swelling developing over hours or days, associated with pain and a feeling of tightness, raises a different clinical question from gradually progressive dependent heaviness present for years. Recent surgery, trauma, periods of immobility, hospital admissions, prolonged travel, known malignancies, pregnancies, the postpartum period, hormonal therapies, previous thromboses and family history should be reviewed. The presence of a venous device, pacemaker or vascular access for cancer treatment points toward a possible local mechanism; repetitive overhead movements or strenuous upper-extremity activity may be relevant in patients with axillosubclavian thrombosis.
This information changes clinical probability, but no single exposure confirms the disease. Likewise, the absence of an identifiable precipitating factor does not exclude it and makes subsequent assessment of recurrence risk more important.
In deep vein thrombosis of the lower extremities, patients may report calf pain, a feeling of tightness or enlargement of the entire limb. The location of pain does not reliably establish the extent of the thrombus, and some events cause few symptoms. Extensive proximal thrombosis may produce marked edema and difficulty walking; distal thrombosis may present with more limited symptoms. Upper-extremity involvement instead causes arm swelling, heaviness, pain and sometimes dilation of superficial chest wall veins.
Superficial vein thrombosis is often described as a painful, reddened and hardened segment of vein. However, its apparent accessibility to inspection does not establish its full extent or exclude concomitant involvement of the deep venous system.
Suspicion of pulmonary involvement arises mainly from new or suddenly worsening dyspnea, pleuritic chest pain, reduced exercise tolerance, syncope or hemoptysis. Symptoms may be subtle in people who already have cardiac or respiratory diseases; in other cases, the initial presentation is collapse. Pleuritic pain suggests peripheral involvement with pleural irritation, whereas syncope requires assessment for possible impairment of cardiac output, although it has many alternative causes. The absence of pain or swelling in a leg does not exclude pulmonary embolism, because the venous source may be clinically silent or no longer demonstrable.
The clinical distinction between hemodynamic instability and apparent stability is a priority. A normotensive person may already have right ventricular overload and a substantial risk of deterioration; thrombus size as described on imaging and pain intensity, considered in isolation, cannot replace this assessment.
In chronic disease, heaviness, swelling and discomfort often tend to worsen after prolonged standing and improve with rest and leg elevation. Itching, burning, cramps and a feeling of tightness are possible but nonspecific. Exercise limitation characterized by limb tightness and slow improvement after stopping walking may suggest venous claudication due to outflow obstruction. A previous ipsilateral thrombotic episode makes post-thrombotic syndrome plausible, but chronic damage must be distinguished from new thrombosis.
For skin lesions, the duration, recurrences, discharge, pain, local treatments and response to compression should be documented. An ulcer that suddenly becomes very painful, is atypical in location or appearance, or is resistant to treatment requires reconsideration of the etiology; not every leg lesion in a patient with varicose veins is a venous ulcer.
Physical examination begins with the general condition, level of consciousness, respiratory and heart rates, blood pressure and oxygen saturation. Cold skin, mottling, oliguria, confusion and hypotension suggest hypoperfusion. Cardiopulmonary assessment looks for signs of right ventricular overload, jugular venous congestion, abnormal heart sounds and respiratory findings that may suggest alternative diagnoses. A largely unremarkable chest examination does not exclude a significant pulmonary embolism.
The limbs should be compared for size, color, temperature and edema, noting any collateral veins. Tenderness along the course of a vein and asymmetry contribute to clinical suspicion but are not pathognomonic. Traditional pain-provoking maneuvers, such as Homans’ sign, lack sufficient accuracy to guide diagnosis. A massively edematous and cyanotic limb, particularly with severe pain and deteriorating perfusion, raises suspicion of a limb-threatening form of venous obstruction.
Examination for chronic venous disease includes, whenever possible, inspection in the standing position and assessment for varicose veins, perimalleolar edema, pigmentation, eczema, lipodermatosclerosis and scars. Ankle mobility, arterial pulses, sensation, signs of lymphedema and features suggesting possible neuropathy should be assessed. Venous ulcers often involve the supramalleolar region, have irregular margins and are accompanied by signs of venous hypertension, but the diagnosis remains based on clinical and instrumental assessment.
The CEAP classification describes the clinical, etiological, anatomical and pathophysiological aspects of the disease. Its clinical component progresses from the absence of visible signs through telangiectasias, varicose veins, edema and skin changes to healed or active ulcers. It is a standardized descriptive tool, not a test that can independently demonstrate the venous origin of every symptom.
There are no single diagnostic criteria encompassing all venous diseases. According to thromboembolism guideline pathways, suspected acute events first require an estimate of pretest probability, followed by investigations selected according to that probability and the patient’s stability. Suspected chronic disease instead requires documentation of reflux, obstruction and the relationship between anatomical findings and clinical manifestations. Confusing these two pathways leads to investigations of limited value, such as using D-dimer to explain unchanged chronic edema or requesting pulmonary angiography without an appropriate clinical question.
D-dimer results from the degradation of cross-linked fibrin and indicates ongoing clot formation and breakdown. Its main utility is to exclude thromboembolism in patients selected through a validated algorithm when the result is negative using a sufficiently sensitive assay. An elevated value does not localize the thrombus or confirm the diagnosis: advanced age, inflammation, pregnancy, malignancy, trauma and surgery can increase D-dimer levels.
Age-adjusted or clinical probability-adjusted thresholds must be applied in the settings in which they have been validated, taking into account the assay and laboratory reporting units. When clinical probability is high, imaging takes priority; a negative result should not be used outside the algorithm to discontinue an assessment that remains necessary. Anticoagulant treatment that has already been started may also affect interpretation.
Compression venous ultrasonography is the cornerstone of investigation for limb thrombosis. A normal vein collapses under pressure from the transducer; failure of a venous segment to compress, in the appropriate context, is the most important finding for identifying thrombosis. Color Doppler imaging and flow assessment provide additional information about patency, proximal obstruction and hemodynamics. The choice between proximal examination and whole-leg assessment influences the subsequent strategy: a negative proximal examination may need to be repeated after approximately one week when significant clinical suspicion persists.
Pelvic veins, certain subclavian segments and regions that are difficult to visualize sometimes require additional imaging techniques. When recurrence is suspected, comparison with previous studies is particularly useful because fibrotic remnants and incomplete compressibility may persist after clinical recovery without representing recent thrombosis.
In pulmonary embolism,CT pulmonary angiography demonstrates arterial filling defects and allows assessment of alternative diagnoses and certain indicators of right ventricular overload. Ventilation/perfusion scintigraphy is an important alternative when iodinated contrast or other patient characteristics make CT less appropriate; interpretation depends on the imaging pattern and clinical context. Echocardiography does not reliably exclude pulmonary embolism in a stable patient, but it assesses hemodynamic consequences and has an urgent role when the patient is too unstable to be transferred.
Troponin and natriuretic peptides may contribute to risk stratification after diagnosis but do not establish the presence of a thrombus. Similarly, hypoxemia, tachycardia and abnormal blood gas findings are nonspecific. The probability of having pulmonary embolism and the probability of deteriorating because of confirmed pulmonary embolism are two separate questions, addressed using different tools.
In chronic disease, duplex ultrasonography must identify the origin and extent of reflux, the patency of the deep venous system and post-thrombotic changes. The examination is performed using positions and maneuvers capable of reproducing the hemodynamic behavior of the venous system; vein diameter alone does not determine the indication for treatment. Marked swelling of the entire limb, suprapubic collateral veins, venous claudication or suspicious Doppler findings may warrant assessment of the iliac veins and vena cava using dedicated ultrasonography, CT or MRI. Intravascular ultrasonography is used in selected settings for planning and treating deep venous obstruction.
Before sustained compression is applied, particularly in the presence of an ulcer or diminished pulses, arterial perfusion must be assessed. The ankle-brachial index may be unreliable in noncompressible arteries, making other measurements, such as toe pressures, necessary. A treatment beneficial for venous hypertension may become harmful if applied without recognizing concomitant severe ischemia.
Following a diagnosis of thromboembolism, precipitating factors, bleeding risk, renal and hepatic function, potential drug interactions and suitability for home management must be established. Investigation for occult malignancy begins with the medical history, examination, basic investigations and age- and sex-appropriate screening; extensive investigations are not automatically justified for every event without an apparent cause. Thrombophilia testing should address a question capable of changing a clinical decision, taking into account interference from the acute phase and medications.
Persistent dyspnea after pulmonary embolism instead requires assessment of functional recovery, comorbidities and possible chronic thromboembolic pulmonary disease. Persistent perfusion defects and organized lesions do not automatically indicate pulmonary hypertension; when pulmonary hypertension is suspected, specialist assessment may include right heart catheterization and evaluation of operability.
Treatment must address the predominant mechanism and the risk arising from it. In thromboembolism,anticoagulation reduces thrombus propagation and the formation of new thrombi while endogenous systems and remodeling processes modify the material already present; it does not produce immediate dissolution of the clot. In chronic venous disease, by contrast, compression, restoration of muscle pump function and selective correction of reflux or obstruction aim to reduce venous hypertension. The mere presence of varicose veins or chronic edema is not an indication for anticoagulant treatment.
For many adults with deep vein thrombosis or pulmonary embolism who are eligible for oral treatment, direct oral anticoagulants are preferred over vitamin K antagonists. The decision differs in pregnancy, certain forms of antiphospholipid syndrome, severe renal impairment, clinically significant interactions and conditions that affect absorption. In patients with cancer, the choice also takes into account tumor location, the risk of mucosal bleeding, platelet count and anticancer treatments.
Treatment duration cannot be determined from a persistent isolated ultrasound finding. Proximal thrombosis or pulmonary embolism generally requires at least three months of treatment; continuation depends on whether the precipitating factor is reversible, recurrence risk, bleeding risk and patient preferences. When a persistent risk is present, secondary prevention without a predetermined end date may be appropriate, with periodic reassessment.
Reperfusion represents a distinct level of treatment. In pulmonary embolism with hemodynamic compromise, systemic thrombolysis, surgical removal or catheter-based procedures can rapidly reduce obstruction, but they carry specific risks and require timely patient selection. In a stable patient, identifying a large thrombus is not sufficient to justify an invasive procedure. European risk classifications and the A–E categories introduced by the 2026 AHA/ACC guidelines use hemodynamic stability, clinical presentation and cardiopulmonary consequences to support decision-making.
Similarly, early thrombus removal in limb thrombosis is reserved for selected situations, such as limb-threatening presentations or certain highly symptomatic iliofemoral thromboses. Inferior vena cava filters are not a routine addition to effective anticoagulation: their use requires a specific justification and, for retrievable devices, a plan for reassessment and removal.
Superficial vein thrombosis requires treatment proportionate to its extent, location, proximity to the deep venous system and individual patient factors. In selected populations studied in clinical trials, a course of fondaparinux reduced thrombus extension and thromboembolic complications; thromboses located very close to deep venous junctions must not be considered equivalent to small isolated distal segments. Ultrasound examination therefore contributes to treatment selection as well as diagnosis.
In primary prevention of thromboembolism, mobilization is useful but does not replace pharmacological prophylaxis when indicated. In hospitalized or surgical patients, thrombotic and bleeding risks must be assessed together; intermittent pneumatic compression may have a role when pharmacological prophylactic anticoagulation is not feasible or as part of appropriate combined strategies. Extended prophylaxis after discharge applies to selected settings, not every hospital admission.
For chronic venous disease, walking, ankle exercises, weight management and reducing immobility improve the functional conditions in which the venous system operates. Compression, selected according to the clinical presentation and arterial perfusion, counteracts edema and distal venous hypertension; effectiveness and adherence depend on correct sizing, the ability to put on the device, skin integrity and tolerance. Venoactive medications may relieve certain symptoms in appropriate patients but do not eliminate structural reflux or significant obstruction.
When superficial reflux is responsible for symptomatic disease, thermal or nonthermal endovenous ablation, sclerotherapy and surgery are options to be selected according to anatomical mapping and patient characteristics. Treatment of iliac obstruction with stenting requires a convincing relationship between the lesion and symptoms; incidental compression alone does not justify stent placement.
In venous ulcers, wound dressings must form part of a program that reduces venous hypertension, controls exudate and pain, and identifies any clinically apparent infections. The EVRA trial demonstrated that, in appropriate patients with superficial reflux and an ulcer, early ablation combined with compression accelerates healing compared with a deferred strategy. However, ulcer closure does not eliminate the predisposition to recurrence, making continued prevention necessary.
Overall prognosis must therefore be considered over two time horizons. In the acute event, circulatory stability, diagnostic timeliness, comorbidities and treatment safety are important; over the long term, recurrences, residual venous damage, cardiopulmonary limitation, bleeding and adherence become important. The goal is not merely to survive the initial phase but to preserve walking ability, independence and quality of life.
Among the long-term consequences of deep vein thrombosis, post-thrombotic syndrome is particularly important because of its frequency and impact. Thrombus organization may leave stenoses and adhesions, while inflammation can damage the valves. Blood thus encounters both an obstacle to outflow and loss of valvular competence, increasing distal venous pressure during everyday activities. Edema, pain, heaviness and skin changes may become persistent; ulceration develops in severe cases. Not every thrombosis leads to this outcome, and the persistence of residual ultrasound abnormalities does not, by itself, measure its clinical severity.
Recurrent thromboembolism depends on the persistence of predisposing conditions, individual history and the adequacy of prevention. It may occur after treatment discontinuation and, less frequently, during apparently appropriate treatment. In the latter case, it is necessary to confirm that the event is new and check adherence, dosage, interactions, absorption and conditions such as active malignancy or antiphospholipid syndrome. Treating every residual thrombus as a recurrence exposes patients to unnecessary treatment intensification, whereas attributing deterioration to chronic sequelae without reassessment may delay an important diagnosis.
New thrombosis in the same limb may further worsen venous hemodynamics and increase disability. A new pulmonary event may have more serious consequences if cardiopulmonary reserve is already reduced.
Acute obstruction of the pulmonary circulation can cause right ventricular failure, shock, organ injury due to hypoperfusion and cardiac arrest. Pulmonary infarction may be associated with pain, hemoptysis and pleural effusion. These manifestations are not uniformly distributed: a small peripheral embolism may be very painful, whereas severe hemodynamic compromise may present mainly with dyspnea, syncope or collapse.
When a communication allows right-to-left passage, a venous thrombus may enter the systemic circulation. Paradoxical embolism may cause stroke or ischemia in other organs; demonstrating a patent foramen ovale alone does not prove that this mechanism caused the event.
Following pulmonary embolism, some patients continue to report reduced exercise tolerance. Causes include deconditioning, pre-existing comorbidities, psychological effects and, in a minority of patients, clinically significant persistence of thromboembolic obstruction. When the material does not resolve but becomes organized into webs, stenoses and fibrotic occlusions, chronic pulmonary vascular disease may develop. Small-vessel remodeling adds a microvascular component to the mechanical obstruction.
Chronic thromboembolic pulmonary hypertension causes progressive right ventricular overload and requires specialist assessment of the potential roles of pulmonary endarterectomy, balloon pulmonary angioplasty and medical therapy. Persistent dyspnea should therefore not be dismissed without investigation, but neither should it automatically be attributed to this complication in the absence of supporting evidence.
Consequences of chronic venous disease include stasis dermatitis, lipodermatosclerosis, ulceration and recurrent ulcers. Fragility of a superficial varicose vein may cause substantial bleeding, especially when the skin and subcutaneous tissue are thinned. Persistent edema may be associated with lymphatic dysfunction and increased vulnerability of the skin barrier; infectious episodes may further impair drainage. However, ulcer colonization and clinical infection are not synonymous, and the presence of bacteria does not automatically justify systemic antibiotic treatment.
Extensive thrombosis may rarely impair venous outflow so profoundly that arterial inflow is also reduced, causing phlegmasia and venous gangrene. Severe pain, cyanosis, massive edema and deteriorating perfusion identify an emergency distinct from ordinary chronic venous insufficiency.
Finally, iatrogenic complications form part of the clinical risk–benefit assessment. Anticoagulants may cause bleeding, ranging from chronic blood loss with anemia to intracranial hemorrhage or bleeding into other critical organs; heparins may cause immune-mediated thrombocytopenia with thrombosis, in which a reduced platelet count is paradoxically accompanied by hypercoagulability. Thrombolysis, vascular procedures and devices introduce additional specific hemorrhagic, thrombotic and local risks. Inappropriate compression may injure the skin or aggravate already critically impaired arterial perfusion.
Follow-up must therefore identify both disease-related and treatment-related consequences. Reassessing symptoms, functional capacity, bleeding, concomitant medications and therapeutic goals helps maintain proportionate care even as the clinical situation changes over time.
Informational notice: the information contained on this page is provided solely for informational and educational purposes and does not replace the advice, diagnosis or treatment provided by a physician. If needed, always consult a qualified healthcare professional.
Artificial intelligence transparency: this page was created with the support of artificial intelligence tools, used to assist in the production and processing of its content.